Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics of Lopinavir/Ritonavir”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Early research (Phase 1)Study completedNCT01148004
What this trial is testing

The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers

Who this might be right for
HIVFenofibrateProtease Inhibitors+2 more
National Institutes of Health Clinical Center (CC) 25
Post-approval studies (Phase 4)Study completedNCT01818258
What this trial is testing

IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children

Who this might be right for
HIV PositiveMalnourished
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 52
Early research (Phase 1)Study completedNCT00723775
What this trial is testing

GSK706769/KALETRA Drug-drug Interaction Study

Who this might be right for
Infection, Human Immunodeficiency Virus
GlaxoSmithKline 17
Early research (Phase 1)Ended earlyNCT00044837
What this trial is testing

Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Testing effectiveness (Phase 2)Study completedNCT00056641
What this trial is testing

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 328
Testing effectiveness (Phase 2)UnknownNCT00017992
What this trial is testing

Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

Who this might be right for
HIV Infections
Triangle Pharmaceuticals 100
Post-approval studies (Phase 4)Ended earlyNCT00420355
What this trial is testing

Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients

Who this might be right for
HIV Infection
University of Oklahoma 19
Post-approval studies (Phase 4)Study completedNCT00810108
What this trial is testing

Lopinavir/Ritonavir (Kaletra) PK in Children

Who this might be right for
HIV/AIDS TreatmentHIV Infections
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 12
Testing effectiveness (Phase 2)Study completedNCT01139905
What this trial is testing

Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children

Who this might be right for
HIV-1 Infections
The HIV Netherlands Australia Thailand Research Collaboration 24
Early research (Phase 1)Study completedNCT01660477
What this trial is testing

Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole

Who this might be right for
Pharmacokinetics of IsavuconazolePharmacokinetics of Lopinavir/RitonavirHealthy Volunteers
Astellas Pharma Global Development, Inc. 68
Testing effectiveness (Phase 2)Study completedNCT02415985
What this trial is testing

Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly

Who this might be right for
HIVTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 40
Not applicableStudy completedNCT00102986
What this trial is testing

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 116
Testing effectiveness (Phase 2)Study completedNCT00184951
What this trial is testing

Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients

Who this might be right for
HIV InfectionsHyperlipidemia
Radboud University Medical Center 30
Early research (Phase 1)Study completedNCT00665951
What this trial is testing

Pharmacokinetic Study of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)

Who this might be right for
HIV Infections
Radboud University Medical Center 12
Post-approval studies (Phase 4)Study completedNCT00564772
What this trial is testing

Raltegravir Kaletra Pharmacokinetics

Who this might be right for
Healthy
Allina Health System 15
Early research (Phase 1)Study completedNCT02159352
What this trial is testing

Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 49
Early research (Phase 1)Study completedNCT00867152
What this trial is testing

GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir

Who this might be right for
Healthy Volunteer
ViiV Healthcare 17
Early research (Phase 1)Study completedNCT00920088
What this trial is testing

Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 24
Testing effectiveness (Phase 2)Study completedNCT00125983
What this trial is testing

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 32
Testing effectiveness (Phase 2)Study completedNCT00109590
What this trial is testing

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 175
Load More Results